All Stories

  1. SIGH, what’s in a name? An examination of the factor structure and criterion validity of the (Structured Interview Guide for the) Hamilton Anxiety scale (SIGH-A) in a sample of African American adults with co-occurring trauma experience and heavy alcoh...

    Article • Experimental and Clinical Psychopharmacology, July 2021, American Psychological Association (APA)

    Daniel Roche

  2. Overcoming the “Valley of Death” in Medications Development for Alcohol Use Disorder

    Article • Alcoholism Clinical and Experimental Research, July 2018, Wiley

    Daniel Roche

  3. Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm

    Article • Neuropsychopharmacology, May 2018, Springer Science + Business Media

    Daniel Roche

  4. Neurobiology of Craving: Current Findings and New Directions

    Article • Current Addiction Reports, May 2018, Springer Science + Business Media

    Daniel Roche

  5. Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial

    Article • Alcoholism Clinical and Experimental Research, February 2018, Wiley

    Daniel Roche

  6. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder

    Article • Psychopharmacology, March 2017, Springer Science + Business Media

    Daniel Roche

  7. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial

    Article • Neuropsychopharmacology, January 2017, Springer Science + Business Media

    Daniel Roche

  8. Relationship between negative affect and smoking topography in heavy drinking smokers

    Article • Addictive Behaviors, October 2016, Elsevier

    Daniel Roche

  9. Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study

    Article • Drug and Alcohol Dependence, May 2016, Elsevier

    Daniel Roche

  10. A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder

    Article • Alcoholism Clinical and Experimental Research, April 2016, Wiley

    Daryl L Davies, Daniel Roche

  11. Current Insights into the Mechanisms and Development of Treatments for Heavy-Drinking Cigarette Smokers

    Article • Current Addiction Reports, February 2016, Springer Science + Business Media

    Daniel Roche

  12. Subjective Response to Alcohol as a Research Domain Criterion

    Article • Alcoholism Clinical and Experimental Research, January 2016, Wiley

    Daniel Roche

  13. Neural substrates of cue reactivity: association with treatment outcomes and relapse

    Article • Addiction Biology, October 2015, Wiley

    Daniel Roche

  14. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers

    Article • Pharmacology Biochemistry and Behavior, July 2015, Elsevier

    Daniel Roche

  15. Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers

    Article • Alcoholism Clinical and Experimental Research, May 2015, Wiley

    Daniel Roche

  16. Subjective response as a consideration in the pharmacogenetics of alcoholism treatment

    Article • Pharmacogenomics, May 2015, Future Medicine

    Daniel Roche

  17. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study

    Article • Neuropsychopharmacology, March 2015, Springer Science + Business Media

    Daniel Roche

  18. Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase

    Article • Psychoneuroendocrinology, February 2015, Elsevier

    Daniel Roche

  19. Neuropsychopharmacology in Addiction Treatment

    Article • January 2015, Springer Science + Business Media

    Daniel Roche

  20. Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study.

    Article • Experimental and Clinical Psychopharmacology, January 2015, American Psychological Association (APA)

    Daniel Roche

  21. The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users

    Article • Drug and Alcohol Dependence, September 2014, Elsevier

    Daniel Roche

  22. Predictors of smoking lapse in a human laboratory paradigm

    Article • Psychopharmacology, February 2014, Springer Science + Business Media

    Daniel Roche

  23. Opportunities for the Development of Neuroimmune Therapies in Addiction

    Article • January 2014, Elsevier

    Daniel Roche

  24. Acute Alcohol Response Phenotype in Heavy Social Drinkers is Robust and Reproducible

    Article • Alcoholism Clinical and Experimental Research, October 2013, Wiley

    Daniel Roche, Andrea King

  25. Hormonal contraceptive use diminishes salivary cortisol response to psychosocial stress and naltrexone in healthy women

    Article • Pharmacology Biochemistry and Behavior, August 2013, Elsevier

    Daniel Roche

  26. Subjective Responses to Alcohol: A Paradigm Shift May Be Brewing

    Article • Alcoholism Clinical and Experimental Research, September 2011, Wiley

    Daniel Roche

  27. Alcohol impairment of saccadic and smooth pursuit eye movements: impact of risk factors for alcohol dependence

    Article • Psychopharmacology, July 2010, Springer Science + Business Media

    Daniel Roche

  28. Acute HPA axis response to naltrexone differs in female vs. male smokers

    Article • Psychoneuroendocrinology, May 2010, Elsevier

    Daniel Roche

  29. Neuropsychopharmacology in Addiction Treatment

    Article • Springer Science + Business Media

    Daniel Roche